Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
QIULE SEEDS
831087
5
LUHENG TECHNOLOGY
870866
US Stock MarketDetailed Quotes
BCAX Bicara Therapeutics
- 9.510
- -1.060-10.03%
Close Apr 7 16:00 ET
- 9.100
- -0.410-4.31%
Pre 04:08 ET
518.52MMarket Cap-7.61P/E (TTM)
10.560High9.021Low487.78KVolume10.240Open10.570Pre Close4.68MTurnover1.73%Turnover RatioLossP/E (Static)54.52MShares28.09052wk High1.05P/B268.80MFloat Cap9.02152wk Low--Dividend TTM28.26MShs Float28.090Historical High--Div YieldTTM14.56%Amplitude9.021Historical Low9.591Avg Price1Lot Size
Bicara Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | |||||||
| Gross profit | |||||||
| Operating expense | 106.55%82.39M | 94.62%26.64M | 116.45%20.63M | 5.93%39.89M | 13.69M | 9.53M | 37.66M |
| Selling and administrative expenses | 102.44%18.77M | 116.13%6.75M | 83.87%4.76M | 46.15%9.27M | --3.13M | --2.59M | --6.34M |
| -General and administrative expense | 102.44%18.77M | 116.13%6.75M | 83.87%4.76M | 46.15%9.27M | --3.13M | --2.59M | --6.34M |
| Research and development costs | 107.79%63.62M | 88.25%19.88M | 128.62%15.86M | -2.22%30.62M | --10.56M | --6.94M | --31.31M |
| Operating profit | -106.55%-82.39M | -94.62%-26.64M | -116.45%-20.63M | -5.93%-39.89M | -13.69M | -9.53M | -37.66M |
| Net non-operating interest income expense | 1,009.67%14.58M | 350.88%5.87M | 24,107.69%3.15M | 1,316.67%1.31M | 1.3M | 13K | -108K |
| Non-operating interest income | 1,009.67%14.58M | 350.88%5.87M | 24,107.69%3.15M | 32,750.00%1.31M | --1.3M | --13K | --4K |
| Non-operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | --112K |
| Other net income (expense) | -16,656.25%-13.41M | -49K | -13.33M | -80K | |||
| Other non- operating income (expenses) | ---- | ---- | ---- | -16,656.25%-13.41M | ---49K | ---13.33M | ---80K |
| Income before tax | -30.45%-67.81M | -67.04%-20.77M | 23.48%-17.48M | -37.35%-51.98M | -12.44M | -22.85M | -37.84M |
| Income tax | 3,640.00%187K | 3,620.00%186K | 0 | 400.00%5K | 5K | 0 | 1K |
| Net income | -30.80%-68M | -68.46%-20.96M | 23.48%-17.48M | -37.36%-51.99M | -12.44M | -22.85M | -37.85M |
| Net income continuous Operations | -30.80%-68M | -68.46%-20.96M | 23.48%-17.48M | -37.36%-51.99M | ---12.44M | ---22.85M | ---37.85M |
| Minority interest income | |||||||
| Net income attributable to the parent company | -30.80%-68M | -68.46%-20.96M | 23.48%-17.48M | -37.36%-51.99M | -12.44M | -22.85M | -37.85M |
| Preferred stock dividends | |||||||
| Other preferred stock dividends | |||||||
| Net income attributable to common stockholders | -30.80%-68M | -68.46%-20.96M | 23.48%-17.48M | -37.36%-51.99M | -12.44M | -22.85M | -37.85M |
| Basic earnings per share | -164.77%-4.05 | -6.54%-0.39 | -138.02%-1.6 | 37.59%-1.5296 | -0.366 | -0.6722 | -2.451 |
| Diluted earnings per share | -164.77%-4.05 | -6.54%-0.39 | -138.02%-1.6 | 37.59%-1.5296 | -0.366 | -0.6722 | -2.451 |
| Dividend per share | |||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call